Juan Francisco Guevara Ramírez

Dr. Juan Francisco Guevara Ramírez

Faculty of Medicine, University of La Sabana, Chía, Colombia
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Advances in Medical Education and Practice
Verified
Journal Article
Open access
PDF file
MDMónica María Díaz-López
Mónica María Díaz-López
HBHelena Bustos-Cruz
Helena Bustos-Cruz
Juan Francisco Guevara RamírezJuan Francisco Guevara Ramírez
Juan Francisco Guevara Ramírez
JGJulio-Cesar García
Julio-Cesar García
Introduction: Nanotechnology has emerged as a promising field of study, aiming to revolutionize healthcare through the innovative development of drugs, diagnostic tools, and medical devices. As a result, healthcare professionals in training are constantly faced with the challenge of understanding and applying these emerging technologies. The objective of this study is to determine the factors to consider for including the teaching of nanotechnological tools in medical specialty postgraduate programs. Methods: A study based on the Nominal Group Technique (NGT) was conducted to identify the factors that promote and hinder the implementation of nanotechnology in certain postgraduate programs where nanotechnology is employed, such as Internal Medicine, Critical Care Medicine, Family Medicine, and Clinical Pharmacology at the School of Medicine of Universidad de La Sabana. A framework analysis was used to analyze the collected data. Results: Based on the two research questions, several aspects were identified for the inclusion of nanotechnology in the medical practice of specialties. Key challenges include lack of knowledge and resource availability, misinformation, and lack of knowledge, as well as paradigmatic analysis as the main obstacles to the use of nanotechnology. Conclusion: The findings provide a first-time study on nanotechnology curricula within medical specialty programs in Colombia, with potential extrapolation to similar situations in other medical schools. These insights can inform the global development of medical education curricula by highlighting the need for structured nanotechnology training, fostering interdisciplinary collaboration, and addressing resource and knowledge gaps to prepare future healthcare professionals for advancing medical technology worldwide.

6 March 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
DNDiego Nivia
Diego Nivia
JVJuan-David Vivas
Juan-David Vivas
WBWilson Briceño
Wilson Briceño
DPDaniel Parra
Daniel Parra
MMManuel Mena
Manuel Mena
HBHelena Bustos-Cruz
Helena Bustos-Cruz
Background Vancomycin is an effective first-line therapy primarily in methicillin-resistant Staphylococcus aureus (MRSA) infection and Clostridium difficile, however, it has been shown that its effectiveness and the reduction of nephrotoxicity depend on maintaining adequate therapeutic levels. Population pharmacokinetic (PopPk) models attempt to parameterize the behavior of plasma concentrations in different target populations and scenarios such as renal replacement therapy, to successful therapeutic outcome and avoid these side effects. Methods A scoping review was conducted following the guidelines of Preferred Reporting Items for Systematic reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR), through a search in PubMed, LILACS, OVID Medline, Scopus, Web of Science, SAGE Journals, Google Scholar and previous known registers of PopPk models in non-critically ill adult patients, published between 1998 and 2024. Results A total of 190 papers were fully screened, of which were included 36 studies conducted in different populations; 12 in general population, 23 in special populations (surgical, with impaired renal function, obese, elderly, with cancer and cystic fibrosis), and 1 in mixed population (general and with cancer). The main parameters in the models were renal clearance and volume of distribution. The principal covariables that affected the models were creatinine clearance and weight. All studies used internal evaluation and 4 of them used an external group. Discussion The technology for the development and implementation of PopPk models requires experts in clinical pharmacology and is limited to university and research centers. The software is mostly expensive and, in most cases, the pharmacokinetic models and the heterogeneity in the parameters and evaluation methods depend on which compartmental model, parameters, covariates and software have been used. Conclusions These models require validation in the clinical context and conducting experiments to adapt them for precision dosing in different subpopulations.

1 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
MDMónica María Díaz-López
Mónica María Díaz-López
HBHelena Bustos-Cruz
Helena Bustos-Cruz
JGJulio Garcia
Julio Garcia
Juan Francisco Guevara RamírezJuan Francisco Guevara Ramírez
Juan Francisco Guevara Ramírez
Background: Nanotechnology has emerged as a promising field of study, aiming to revolutionize healthcare through the innovative development of drugs, diagnostic tools, and medical devices. As a result, healthcare professionals in training are constantly faced with the challenge of understanding and applying these emerging technologies. The objective of this study is to determine the factors to consider for including the teaching of nanotechnological tools in medical specialty postgraduate programs. Methods: A study based on the Nominal Group Technique (NGT) was conducted to identify the factors that promote and hinder the implementation of nanotechnology in certain postgraduate programs where nanotechnology is employed, such as Internal Medicine, Critical Care Medicine, Family Medicine, and Clinical Pharmacology at the School of Medicine of Universidad de La Sabana. A framework analysis was used to analyze the collected data. Results: Based on the two research questions, several aspects were identified for the inclusion of nanotechnology in the medical practice of specialties. Key challenges include lack of knowledge and resource availability, misinformation, and lack of knowledge, as well as paradigmatic analysis as the main obstacles to the use of nanotechnology. Conclusions: The findings provide a first-time study on nanotechnology curricula within medical specialty programs in Colombia, with potential extrapolation to similar situations in other medical schools.

16 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
Juan Francisco Guevara RamírezJuan Francisco Guevara Ramírez
Juan Francisco Guevara Ramírez
AGAndrés Felipe Rodríguez Gutiérrez
Andrés Felipe Rodríguez Gutiérrez
IEIngrid Sofía Sánchez Escobar
Ingrid Sofía Sánchez Escobar
SRSamuel David Bolaños Rodríguez
Samuel David Bolaños Rodríguez
VRValentina Adames Restrepo
Valentina Adames Restrepo
SBSamuel Barbosa
Samuel Barbosa
Purpose: The growing use of high-flow nasal cannula (HFNC) in pediatric inpatient settings raises questions about its efficacy, safety, and cost-effectiveness compared to other non-invasive ventilation (NIV) systems. This scoping review synthesizes available evidence on the indications, benefits, and risks of HFNC in the pediatric population to identify its primary applications and key research priorities. Methods: We conducted a scoping systematic review by retrieving articles from PubMed, Scopus, and Google Scholar databases, adhering to PRISMA-ScR guidelines. Studies published since 2017 were included, with a focus on the application of HFNC in bronchiolitis, asthma, pneumonia, and obstructive sleep apnea (OSA). Key parameters analyzed included dosing, clinical indications, and efficacy outcomes. Results: Among the 44 selected articles, the evidence demonstrated mixed results across different pathologies. The strongest supporting evidence was consistently observed in the treatment of bronchiolitis and its effective use as a rescue or intermediate therapy in critical conditions. Conclusions: The absence of standardized protocols and variability in dosing limit the widespread application of HFNC. While initial costs are reportedly high, its use may reduce the need for other therapeutic resources and pediatric intensive care unit (PICU) stays, offering long-term economic benefits. There is an urgent need for rigorously designed controlled studies to establish clear indications, optimize its use, and promote its inclusion in pediatric respiratory management guidelines.

6 November 2025 in Research Square
Verified
Preprint
Open access
PDF file
Juan Francisco Guevara RamírezJuan Francisco Guevara Ramírez
Juan Francisco Guevara Ramírez
AGAndrés Felipe Rodríguez Gutiérrez
Andrés Felipe Rodríguez Gutiérrez
IEIngrid Sofía Sánchez Escobar
Ingrid Sofía Sánchez Escobar
SRSamuel David Bolaños Rodríguez
Samuel David Bolaños Rodríguez
VRValentina Adames Restrepo
Valentina Adames Restrepo
SBSamuel Barbosa
Samuel Barbosa
Purpose The growing use of high-flow nasal cannula (HFNC) in pediatric inpatient settings raises questions about its efficacy, safety, and cost-effectiveness compared to other non-invasive ventilation (NIV) systems. This scoping review synthesizes available evidence on the indications, benefits, and risks of HFNC in the pediatric population to identify its primary applications and key research priorities. Methods We conducted a scoping systematic review by retrieving articles from PubMed, Scopus, and Google Scholar databases, adhering to PRISMA-ScR guidelines. Studies published since 2017 were included, with a focus on the application of HFNC in bronchiolitis, asthma, pneumonia, and obstructive sleep apnea (OSA). Key parameters analyzed included dosing, clinical indications, and efficacy outcomes. Results Among the 44 selected articles, the evidence demonstrated mixed results across different pathologies. The strongest supporting evidence was consistently observed in the treatment of bronchiolitis and its effective use as a rescue or intermediate therapy in critical conditions. Conclusions The absence of standardized protocols and variability in dosing limit the widespread application of HFNC. While initial costs are reportedly high, its use may reduce the need for other therapeutic resources and pediatric intensive care unit (PICU) stays, offering long-term economic benefits. There is an urgent need for rigorously designed controlled studies to establish clear indications, optimize its use, and promote its inclusion in pediatric respiratory management guidelines.

1 July 2026 in Investigación en Educación Médica
Verified
Journal Article
Closed access
IPIvón Andrea Paredes-Cañón
Ivón Andrea Paredes-Cañón
Juan Francisco Guevara RamírezJuan Francisco Guevara Ramírez
Juan Francisco Guevara Ramírez
Introducción: La realidad extendida (XR) es una herramienta innovadora en educación médica pediátrica, clave para reanimación neonatal y emergencias. Este estudio sintetiza críticamente la evidencia actual sobre su efectividad, barreras de implementación e impacto en la adquisición y retención de habilidades clínicas. Objetivo: Determinar el impacto de las tecnologías de XR en la adquisición y retención de habilidades clínicas en la educación médica pediátrica según sus factores determinantes de efectividad y adopción en diversos contextos de aprendizaje. Método: Se realizó una revisión panorámica rigurosa siguiendo PRISMA-ScR. La búsqueda abarcó PubMed, Scopus y Google Scholar (2018-2024), seleccionando estudios originales y revisiones sobre XR en educación pediátrica. Dos revisores independientes extrajeron y categorizaron datos: efectividad, limitaciones y aplicaciones. Resultados: De 22 estudios, la XR mejoró retención teórica, confianza clínica y habilidades no técnicas. En contextos de bajos recursos, estudios de reanimación neonatal con XR alcanzaron tasas de aprobación de hasta el 76% en el Examen Clínico Objetivo Estructurado (ECOE), demostrando efectividad comparable o superior a los métodos tradicionales en ciertas poblaciones. Se identificó evidencia contradictoria en habilidades psicomotoras, alta incidencia de cibermareo (hasta 40%), falta de estandarización métrica y escasa investigación cualitativa (5.33%). La XR móvil en recursos limitados mostró brechas en infraestructura y acceso. Discusión: La XR valora la simulación segura, accesibilidad y motivación. No obstante, enfrenta desafíos como evidencia inconsistente en habilidades psicomotoras, efectos adversos, altos costos, falta de estandarización evaluativa y escasez de estudios longitudinales y cualitativos. Conclusiones: La XR es un complemento prometedor. Su adopción exige marcos pedagógicos estandarizados, estudios longitudinales, integración curricular equitativa, mitigación de barreras técnicas y sinergia con metodologías tradicionales para maximizar su potencial.